Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Nov 30 04:00PM ET
7.81
Dollar change
-1.60
Percentage change
-17.00
%
Index- P/E4.02 EPS (ttm)1.94 Insider Own0.02% Shs Outstand2.45M Perf Week4.97%
Market Cap19.13M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.45M Perf Month38.97%
Income0.29M PEG- EPS next Q- Inst Own0.01% Short Float / Ratio0.29% / 0.00 Perf Quarter87.74%
Sales3.32M P/S5.76 EPS this Y- Inst Trans- Short Interest0.01M Perf Half Y-63.81%
Book/sh14.46 P/B0.54 EPS next Y- ROA2.36% Target Price520.00 Perf Year-69.96%
Cash/sh0.87 P/C9.03 EPS next 5Y- ROE8.05% 52W Range2.80 - 34.58 Perf YTD-60.24%
Dividend- P/FCF- EPS past 5Y-62.50% ROI7.01% 52W High-77.41% Beta1.85
Dividend %- Quick Ratio0.96 Sales past 5Y0.00% Gross Margin47.12% 52W Low178.93% ATR1.65
Employees3 Current Ratio1.17 Sales Q/Q- Oper. Margin-194.06% RSI (14)56.54 Volatility32.49% 20.86%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin8.65% Rel Volume0.25 Prev Close9.41
ShortableNo LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.98M Price7.81
Recom1.00 SMA2019.71% SMA5050.38% SMA200-31.82% Volume499,369 Change-17.00%
Nov-28-23 08:55AM
08:25AM
Nov-27-23 08:41AM
Nov-24-23 08:55AM
Nov-22-23 09:49AM
07:42AM Loading…
07:42AM
Nov-15-23 10:55AM
08:01AM
Nov-10-23 09:10AM
Oct-31-23 11:08AM
07:38AM
Oct-24-23 07:20AM
Oct-17-23 08:00AM
Oct-16-23 09:45AM
08:17AM
04:28PM Loading…
Oct-13-23 04:28PM
Oct-11-23 09:15AM
Oct-03-23 07:33AM
Sep-29-23 07:45AM
Sep-27-23 07:58AM
Sep-20-23 06:30AM
Sep-12-23 09:15AM
Sep-07-23 09:15AM
06:00AM
Aug-15-23 09:50AM
Aug-14-23 12:20PM
Aug-10-23 09:10AM
Aug-09-23 04:40PM
Aug-01-23 10:30AM
09:00AM
09:00AM Loading…
09:00AM
Jul-14-23 07:55AM
Jun-30-23 09:25AM
Jun-21-23 10:30AM
09:00AM
Jun-16-23 09:05AM
09:05AM
Jun-07-23 08:05AM
08:05AM
Jun-02-23 09:00AM
May-30-23 08:40AM
May-08-23 06:35AM
May-02-23 07:25AM
Apr-21-23 08:30AM
08:30AM
Apr-04-23 08:15AM
Mar-28-23 09:00AM
Mar-10-23 04:15PM
Mar-09-23 07:30AM
Mar-06-23 07:45AM
Feb-27-23 09:11AM
Feb-23-23 08:45AM
08:30AM
Feb-22-23 08:00AM
08:00AM
Feb-17-23 08:00AM
Feb-15-23 08:30AM
08:30AM
Jan-25-23 08:30AM
Jan-23-23 02:15PM
09:20AM
Jan-18-23 07:30AM
Jan-17-23 08:30AM
Jan-09-23 08:30AM
Jan-05-23 09:00AM
Dec-14-22 09:15AM
Dec-07-22 08:40AM
Nov-29-22 08:00AM
Nov-15-22 10:25AM
09:15AM
Nov-08-22 07:00AM
Nov-07-22 08:45AM
Nov-01-22 08:30AM
Oct-28-22 07:45AM
Oct-12-22 09:00AM
Sep-30-22 07:00AM
Sep-22-22 08:30AM
07:46AM
Sep-14-22 07:35AM
Aug-24-22 07:30AM
Aug-19-22 06:45AM
Aug-18-22 08:15AM
Aug-15-22 08:30AM
Aug-12-22 08:00AM
Aug-08-22 08:55AM
Aug-01-22 09:30AM
Jul-21-22 07:22AM
Jul-08-22 08:30AM
Jul-07-22 08:30AM
08:00AM
Jul-06-22 09:31AM
08:30AM
Jun-29-22 08:30AM
Jun-23-22 09:30AM
Jun-15-22 08:30AM
Jun-09-22 08:30AM
Jun-07-22 08:30AM
Jun-02-22 09:55AM
08:30AM
Jun-01-22 04:07PM
SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and Brain Bright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. Its products include SCI-110, SCI-210, SCI-160, and CannAmide. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.